☆ 4.7 Article

Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness

JOURNAL OF INFECTIOUS DISEASES (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Medicine, General & Internal

Association of COVID-19 Vaccination With Symptomatic SARS-CoV-2 Infection by Time Since Vaccination and Delta Variant Predominance

Amadea Britton et al.

Summary: This study examines the associations between COVID-19 vaccination and symptomatic SARS-CoV-2 infection, particularly during the Delta variant period. The findings suggest a lower vaccine effectiveness during the Delta variant period and a gradual attenuation of vaccine effectiveness over time.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants

Emma K. Accorsi et al.

Summary: Assessing the performance of COVID-19 vaccines against the Omicron variant is crucial for public health guidance. This study found that receiving three doses of mRNA COVID-19 vaccine was associated with a lower likelihood of symptomatic SARS-CoV-2 infection compared to being unvaccinated or receiving two doses. These findings suggest that three doses of mRNA vaccine provide protection against both Omicron and Delta variants, though the protection against Omicron may be slightly lower.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Medicine, General & Internal

Comparative Effectiveness of BNT162b2 and mRNA-1273 Vaccines in US Veterans

Barbra A. Dickerman et al.

Summary: The mRNA vaccines BNT162b2 and mRNA-1273 showed high efficacy in preventing COVID-19 infection, hospitalization, and death among nearly 440,000 veterans observed in the study. There was a 21% lower risk of infection with mRNA-1273 compared to BNT162b2. The study covered periods when either the alpha or delta variants of the virus were dominant.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

Nick Andrews et al.

Summary: A study conducted in England showed that vaccines against SARS-CoV-2 provide high protection against hospitalization and death from Covid-19 at 20 weeks or more after vaccination. However, the effectiveness of the vaccines decreases over time, especially in individuals aged 65 and older and those with underlying risk factors.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Medicine, General & Internal

Covid-19 Vaccine Effectiveness in New York State

Eli S. Rosenberg et al.

Summary: The effectiveness of the BNT162b2, mRNA-1273, and Ad26.COV2.S vaccines in New York State from May to August 2021 was assessed. Initial protection was high, but there was a modest decline in effectiveness after the surge of the delta variant, especially among recipients aged 65 and older. However, protection against hospitalization remained high.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

添加到收藏夹

Article Immunology

Cohort study of Covid-19 vaccine effectiveness among healthcare workers in Finland, December 2020-October 2021

Eero Poukka et al.

Summary: Recently, the effectiveness of Covid-19 vaccines, especially against mild disease, has decreased due to the emergence of the Delta variant and waning protection. A register-based study in Finland found that the vaccine effectiveness of two-dose mRNA vaccine series against SARS-CoV-2 infection decreased from 82% to 53% after 6 months. Similar trends were observed for other vaccine series. Waning protection was not observed against Covid-19 hospitalization. These results inform decision-making regarding booster doses for healthcare workers.

VACCINE (2022)

添加到收藏夹

Article Immunology

Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada

Danuta M. Skowronski et al.

Summary: Test-negative design studies conducted in British Columbia and Quebec, Canada, among adults show that 2 doses of homologous or heterologous SARS-CoV-2 vaccines provide substantial and sustained protection against hospitalization, supporting the use of mixed schedules and longer intervals between doses.

CLINICAL INFECTIOUS DISEASES (2022)

添加到收藏夹

Editorial Material Medicine, General & Internal

Efficiency decreases

Halane Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2022)

添加到收藏夹

Article Medicine, General & Internal

Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study

Adam S. Lauring et al.

Summary: mRNA vaccines were highly effective in preventing covid-19 associated hospital admissions related to the alpha, delta, and omicron variants. Three vaccine doses were required for protection against omicron, while two doses provided protection against delta and alpha variants. Omicron variant showed lower disease severity compared to delta variant but still resulted in morbidity and mortality. Vaccinated patients had lower disease severity than unvaccinated patients for all the variants.

BMJ-BRITISH MEDICAL JOURNAL (2022)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 COVID-19 Vaccines Among US Military Personnel Before and During the Predominance of the Delta Variant

Angelia A. Eick-Cost et al.

Summary: This case-control study aimed to evaluate the effectiveness of mRNA-1273, BNT162b2, and JNJ-78436735 vaccines among US military personnel before and during the predominance of the Delta variant. The study found that the effectiveness of all vaccines was significantly lower during the Delta period compared to the pre-Delta period, especially for the JNJ-78436735 vaccine.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Review Medicine, General & Internal

Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression

Daniel R. Feikin et al.

Summary: This study systematically reviewed the duration of protection provided by COVID-19 vaccines against various clinical outcomes. The findings indicate that the effectiveness or efficacy of the vaccines decreased from 1 to 6 months after full vaccination, but remained high against severe disease. Evaluating the effectiveness or efficacy of vaccines beyond 6 months is crucial for updating vaccine policies.

LANCET (2022)

添加到收藏夹

Article Immunology

Comparative Effectiveness of Coronavirus Vaccine in Preventing Breakthrough Infections among Vaccinated Persons Infected with Delta and Alpha Variants

Irina Kislaya et al.

Summary: In this case-case study, we found lower effectiveness of mRNA vaccines in preventing Delta variant infection compared to Alpha variant. Delta-infected patients had significantly higher odds of vaccine breakthrough infection and were more infectious than Alpha variant cases.

EMERGING INFECTIOUS DISEASES (2022)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof et al.

Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.

LANCET (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar

Patrick Tang et al.

Summary: mRNA COVID-19 vaccines demonstrate high effectiveness in preventing severe outcomes and death caused by the Delta variant in Qatar, despite lower effectiveness at blocking infection.

NATURE MEDICINE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Koen B. Pouwels et al.

Summary: A large, community-based study in the United Kingdom indicates that the effectiveness of BNT162b2 and ChAdOx1 vaccines against SARS-CoV-2 infections with symptoms or high viral burden is reduced with the Delta variant compared to the Alpha variant. Although the effectiveness of two doses is at least as great as protection afforded by prior natural infection, there are significant differences in the dynamics of immunity after the second dose between BNT162b2 and ChAdOx1.

NATURE MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning Immunity after the BNT162b2 Vaccine in Israel

Yair Goldberg et al.

Summary: The immunity against the delta variant of SARS-CoV-2 waned in all age groups in Israel a few months after receiving the second dose of the vaccine, leading to an increase in infection and severe cases.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar

Hiam Chemaitelly et al.

Summary: In a study conducted in Qatar involving over 900,000 participants, vaccine effectiveness peaked at 77.5% in the first month after the second dose. However, it declined afterwards to as low as 20% in months 5 through 7 after vaccination, while protection against severe Covid-19 remained above 90% for at least 6 months.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in Sao Paulo

Matt D. T. Hitchings et al.

Summary: This study conducted in Sao Paulo state, Brazil, investigated the effectiveness of the ChAdOx1 vaccine in adults aged 60 years and older against the Gamma variant of the Covid-19 virus. The results showed that the two-dose schedule of the ChAdOx1 vaccine provided significantly increased protection against Covid-19, hospitalization, and death compared to a single dose in elderly individuals during widespread circulation of the Gamma variant.

NATURE COMMUNICATIONS (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study

Katia J. Bruxvoort et al.

Summary: The study evaluated the effectiveness of mRNA-1273 vaccine against SARS-CoV-2 variants, especially the delta variant, by time since vaccination. Two doses of the vaccine showed high effectiveness against all variants, with a decline in effectiveness against delta variant over time. One dose of the vaccine also demonstrated moderate effectiveness against delta infection.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Letter Medicine, General & Internal

Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants

Laith J. Abu-Raddad et al.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Infectious Diseases

Vaccine effectiveness against infection with the Delta (B.1.617.2) variant, Norway, April to August 2021

Elina Seppala et al.

Summary: This population-based cohort study found that the vaccine effectiveness against the Delta variant was significantly lower for partially vaccinated individuals at 22.4% compared to 64.6% for fully vaccinated individuals, when compared to vaccine effectiveness against the Alpha variant at 54.5% and 84.4% respectively.

EUROSURVEILLANCE (2021)

添加到收藏夹

Editorial Material Medicine, General & Internal

Covid-19 Vaccine Effectiveness and the Test-Negative Design

Natalie E. Dean et al.

Summary: Observational studies are becoming crucial for assessing vaccine effectiveness, especially when large randomized controlled trials are not feasible. These studies can monitor vaccine efficacy waning and assess the effectiveness against new coronavirus variants.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

添加到收藏夹

Article Medicine, General & Internal

Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study

Otavio Ranzani et al.

Summary: The study evaluates the effectiveness of the CoronaVac vaccine in the elderly population aged >= 70 years in Sao Paulo state, Brazil during widespread circulation of the gamma variant. The vaccine was found to significantly reduce the risk of symptomatic covid-19, hospital admissions, and deaths after completion of the two-dose regimen, but the effectiveness decreases with age among the elderly population.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant — National Healthcare Safety Network, March 1–August 1, 2021

Srinivas Nanduri et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Public, Environmental & Occupational Health

Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021

Ashley Fowlkes et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

添加到收藏夹

Article Health Care Sciences & Services

Agile Health Care Analytics: Enabling Real-Time Disease Surveillance With a Computational Health Platform

Wade L. Schulz et al.

JOURNAL OF MEDICAL INTERNET RESEARCH (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Data, disease and diplomacy: GISAID's innovative contribution to global health

Stefan Elbe et al.

GLOBAL CHALLENGES (2017)

添加到收藏夹

Article Health Care Sciences & Services

A comparison of methods to adjust for continuous covariates in the analysis of randomised trials

Brennan C. Kahan et al.

BMC MEDICAL RESEARCH METHODOLOGY (2016)

添加到收藏夹

Article Medicine, General & Internal

Adjustment for continuous confounders: an example of how to prevent residual confounding

Rolf H. H. Groenwold et al.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2013)

添加到收藏夹

Article Infectious Diseases

The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials

G De Serres et al.

Eurosurveillance (2013)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.